(Q40975989)

25 September 2017

1 reference

title

Breast cancer in elderly women: presentation, survival, and treatment options (English)

1 reference

25 September 2017

Law TM

1

1 reference

25 September 2017

Hesketh PJ

2

1 reference

25 September 2017

Porter KA

3

1 reference

25 September 2017

Lawn-Tsao L

4

1 reference

25 September 2017

McAnaw R

5

1 reference

25 September 2017

Lopez MJ

6

1 reference

25 September 2017

publication date

1 April 1996

1 reference

Surgical Clinics of North America

25 September 2017

published in

1 reference

25 September 2017

volume

76

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

289-308

1 reference

The relation between survival and age at diagnosis in breast cancer.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast cancer in the elderly. Current patterns of care

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Cancer chemotherapy in the elderly: a series of 51 patients aged greater than 70 years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

1 reference

7 January 2021

The effect of age on treatment choice and survival in elderly breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Treatment of metastatic breast cancer in estrogen receptor positive patients. A randomized trial comparing tamoxifen alone versus tamoxifen plus CMF

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

The effect of age on the care of women with breast cancer in community hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Issues in breast cancer screening in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Age does not predict breast cancer outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Characteristics of breast cancer in women over 80 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Clinical efficacy of mammographic screening in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Report of the International Workshop on Screening for Breast Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Stage at diagnosis of cancer varies with the age of the patient

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Mammography and age: are we targeting the wrong women? A community survey of women and physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Survival following breast cancer surgery in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Cancer stage-to-age relationship: implications for cancer screening in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Use of tamoxifen for breast cancer: twenty-eight years later

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Does cancer survival differ for older patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus plus postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Tamoxifen as an alternative to surgical resection for selected geriatric patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Management of breast cancer in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Factors affecting recurrence in lumpectomy without irradiation for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Once weekly irradiation in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

The effect of comorbidity on 3-year survival of women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast cancer in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Representation of older patients in cancer treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Radiotherapy after breast-preserving surgery in women with localized cancer of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Assessment of malignancy potential in mammary carcinoma in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast cancer in the elderly patient: early detection with mammography.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast irradiation in the older woman: a toxicity study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970440-0

7 January 2021

10.1016/S0039-6109(05)70440-0

Identifiers

DOI

1 reference

25 September 2017

1 reference